ECMO is specialized enough that the learning curve carries real clinical and financial consequences, and there is no shortcut to the institutional knowledge that takes years to accumulate. The post Four Reasons ECMO Programs Stall appeared first on MedCity News.
Healthcare leaders must recognize this impending shift now and get ready for it by changing how they evaluate technology and the operational tasks they expect it to solve. The post The Current “SaaS Meltdown” Will Fundamentally Change the Tech Stack by 2027 appeared first on MedCity News.
The FDA’s recent decision to withhold approval of a new skin cancer treatment fell like a hammer on doctors who treat melanoma and patients who saw that the drug had prolonged the lives of a third of the participants in a clinical trial. “It was devastating news,” said Trisha Wise-Draper, a dermatologist at the University…
Minnesota lawmakers are wrestling with how to sustain the state’s financially distressed hospitals while patients confront growing medical debt. One Minnesota lawmaker wants to steer money from an existing healthcare tax back to hospitals so they can expand their charity care programs for patients who can’t afford their bills. The proposal follows a Minnesota Star…
Health and Human Services Secretary Robert F. Kennedy Jr. is caught between his Make America Healthy Again supporters who want him to do more to advance their priorities, including curtailing vaccines, and a White House trying to combat President Donald Trump’s unpopularity. Protesters’ chants could be heard from inside the Cleveland City Club, where Kennedy…
Shyld AI has raised $13.4 million to expand its AI-powered UV disinfection platform, which autonomously sanitizes hospital rooms. The startup’s technology aims to reduce the risk of hospital-acquired infection, as well as lessen hospitals’ reliance on labor-intensive cleaning workflows. The post Shyld AI Snags $13M for Device that Disinfects Hospital Rooms Autonomously appeared first on…
BeOne Medicines drug Beqalzi has accelerated FDA approval for treating relapsed or refractory mantle cell lymphoma, a type of blood cancer. The regulatory nod opens the door to potentially compete against Venclexta, a blockbuster cancer drug marketed by AbbVie and Roche. The post FDA Approval Gives BeOne Medicines a New Challenger to AbbVie, Roche Cancer…
At this year’s Healthcare Innovation Summit in Washington, D.C., healthcare leaders tackled some of the industry’s biggest challenges — from AI governance and cybersecurity to interoperability, digital medicine and operational transformation. Here are just a few of the conversations and themes that stood out throughout the day.
Twin Health CMO Lisa Shah, M.D., describes how her company makes highly personalized recommendations to help users reach goals such as a lower A1C
Carrot is expanding its AI-powered metabolic health program to support menopause care, offering personalized guidance and wearable integration. The post Carrot Expands AI Metabolic Health Program to Menopause appeared first on MedCity News.